Investigator-initiated studies
Professionally led concepts with defined hypotheses and governance.
A structured route for investigator-led, clinic-based, observational and platform-validation studies.
A structured route for investigator-led, clinic-based, observational and platform-validation studies.
Study concepts are assessed for scientific merit, feasibility, ethics, regulatory requirements, material availability and strategic fit.
ChronoSense® connects the biological hypothesis to delivery, evidence, data and a controlled route to market.
Professionally led concepts with defined hypotheses and governance.
Practice-based protocols using appropriate endpoints and controls.
Longitudinal rhythm, behavior or outcome data where ethically suitable.
Delivery, biomarker, wearable or personalization studies.
Authorship, registration and dissemination discussed in advance.
Privacy, consent, data ownership and access defined before launch.
The platform is designed to move through explicit stages, with evidence and access appropriate to each one.
Confirm credentials, jurisdiction and requested access.
Accept confidentiality, use and disclosure requirements where applicable.
Access is limited to the evidence and program relevant to the approved role.
Use meetings, studies, education and feedback under clear governance.
Describe the hypothesis, population, design, endpoints, site capability and expected contribution.